Immunome Inc (IMNM) Earnings Report, Financial Results, Financial analysis

Immunome inc narrowed IV. Quarter net loss per share of $-0.79 compare to net loss per share of $-7.52 recorded in the same quarter a year ago a decrease compare to $-0.46 realized in previous quarter.

*IV. Quarter*
Earnings Per Share	Revenues
$ -0.79	$ 6 Mill
$+6.73	$+11M

Immunome Inc 's Revenue rose by -200 % in IV. Quarter (Dec 31 2022) year on year, to $6 million and advanced by sequentially.

Immunome Inc is Expected to report next financial results on March 27, 2023.

More on IMNM's Income Statement

IMNM's NET INCOME

Immunome Inc 's in IV. Quarter recorded net loss of $-20.002 million, an increase from net loss of $-8.377 million in III. Quarter a year ago.

Sequentially net loss advanced

More on IMNM's Growth

Immunome Inc Inventories
In IV. Quarter company's net cash and cash equivalents decreased by $0 million

Earnings quality

Immunome inc does not pay out common stock dividend.

In trailing twelve-month period Immunome inc payed $ -1.10 cash per share, on a free-cash flow basis .

Book value fell by -74.08 % sequentially to $1.37 per share, -563.45% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 1.37 per share from $ 5.29.

Company issued 0.68 million shares or 5.98 % in IV. Quarter.
Interest Coverage Ratio was 1116.93. Debt Coverage Ratio was 67.02.

• More on IMNM's Dividends

Market Capitalization (Millions)	68
Shares Outstanding (Millions)	12
Total Debt (Millions $)	-
Revenue (TTM) (Millions $)	11
Net Income (TTM) (Millions $)	-21
Cash Flow (TTM) (Millions $)	53
Capital Exp. (TTM) (Millions $)	0
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Earnings quality

Immunome inc does not pay out common stock dividend.

In trailing twelve-month period Immunome inc had negative $ -1.10 cash flow per share, on a free-cash flow basis .

Book value fell by -74.08 % sequentially to $1.37 per share, -563.45% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 1.37 per share from $ 5.29.

Company issued 0.68 million shares or 5.98 % in IV. Quarter.
Interest Coverage Ratio was 1116.93. Debt Coverage Ratio was 67.02.

• More on IMNM's Balance Sheets

Market Capitalization (Millions)	68
Shares Outstanding (Millions)	12
Total Debt (Millions $)	-
Revenue (TTM) (Millions $)	11
Net Income (TTM) (Millions $)	-21
Cash Flow (TTM) (Millions $)	53
Capital Exp. (TTM) (Millions $)	0
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar GNE's Profile Stock Price GNE's Financials Business Description Fundamentals Charts & Quotes GNE's News Suppliers GNE's Competitors Customers & Markets Economic Indicators GNE's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Immunome inc

IMNM's Financial Statements and Analysis